Preparations to sue follow a two-year probe into whether the firms steer patients away from less-expensive medicines.
Related Posts
Target Shares Plunge on Earnings Miss
The retailer says spending remains sluggish for apparel, TVs and home goods.
Equinor Buys 9.8% Stake in Orsted as Part of Renewables Push
Equinor plans to allocate more than 50% of its investments in renewable and low-carbon projects by 2050, from around 20% in 2023.
Energy & Utilities Roundup: Market Talk
Find insight on Seatrium, Tenaga Nasional and more in the latest Market Talks covering Energy and Utilities.